Staska Phaimaceuticals, fuc

Form 483 issued February 20, 2026 · Bennet, Nebraska

Inspection
Feb 9 – Feb 20, 2026
Observations
3
Pages
5
FEI number
3017473850

In short: On February 20, 2026, FDA issued a Form 483 with 3 observations to Staska Phaimaceuticals, fuc in Bennet, Nebraska (FEI 3017473850) after an inspection that ran Feb 9 – Feb 20, 2026. The investigators were Carl A. Huffman and Chad W. Rice. Most observations concern quality system and laboratory controls.

At a glance

Quality system and laboratory controls account for 2 of 3 observations.

Quality system1
Laboratory controls1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

  2. 02

    Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards, sampling plans…

  3. 03

    Observation 3: scanned text, readable in the full document.

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Staska Phaimaceuticals, fuc?

FDA listed 3 observations on this Form 483, mostly about quality system, laboratory controls and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Staska Phaimaceuticals, fuc?

Carl A. Huffman and Chad W. Rice are named on this Form 483, for the inspection of Feb 9 – Feb 20, 2026. Each investigator has a profile showing what they cite most.

When was Staska Phaimaceuticals, fuc inspected by FDA?

The inspection ran Feb 9 – Feb 20, 2026, and the Form 483 is dated February 20, 2026.

How do I get the full Form 483 for Staska Phaimaceuticals, fuc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free